Healthtech startup Bonatra has acquired women's health and wellness firm MyAva to expand its offerings and become a one-stop platform for chronic health condition management. MyAva provides personalized plans for women to manage conditions such as PCOS, thyroid disorders, and insulin resistance. Meanwhile, Bonatra specializes in IoMT to manage diseases including hypertension, diabetes, PCOD, and obesity, using personalized treatment based on data analysis. The company's holistic solutions include targeted lifestyle, nutritional, and fitness interventions. Bonatra also plans to introduce new IoMT devices, including a smart ring, in India within six months.
Bonatra, a healthtech startup, has announced its acquisition of women’s health and wellness company MyAva, in a move to expand its holistic healthcare programs and become a one-stop platform for the management of chronic health conditions. MyAva is a femtech startup that provides curated programs and personalized plans to help women manage chronic health conditions such as PCOS, thyroid disorders, insulin resistance, and more.
Meanwhile, Bonatra is an IoMT (Internet of Medical Things) startup that focuses on treating and managing chronic diseases such as diabetes, hypertension, fatty liver, PCOD, and obesity, using personalized treatment arrived at after analyzing multiple data points and health parameters using various IoMT devices.
MyAva, A Women’s Health And Wellness Startup, Has Been Acquired By HealthTech Startup Bonatra
Bonatra, founded in April 2022 by Rahul Kishore Singh (CEO), Manjari Chandra (CMO), Ramanpreet Singh (COO), and Amit Acharya (CTO), integrates clinical acumen with technology to achieve holistic health. Its solutions include personalized, targeted lifestyle, nutritional, and fitness interventions to balance hormones and supplement them with other functional methods such as gut reset, correcting gut dysbiosis, and harnessing natural detox procedures to reduce heavy metal toxicity in the body.
Rahul Kishore Singh, CEO and Co-Founder of Bonatra, said in a statement, “We are thrilled to welcome MyAva to join the Bonatra family. Acquiring MyAva enables us to expand our reach and deepen our expertise in women’s health, specifically for conditions like PCOS.” Over the next six months, Bonatra plans to introduce newer IoMT devices, including a smart ring in the Indian market, to further strengthen its solutions, which are a convergence of medical science, data science, and technology.
“MyAva is elated to join Bonatra and further the vision of making chronic care management accessible to all women. We believe this further strengthens our combined commitment towards making femtech more inclusive and integrated,” said Evelyn Immanuel, Founder and CEO of MyAva.
Bonatra is a healthtech startup that focuses on treating and managing chronic diseases using personalized treatments arrived at after analyzing multiple data points and health parameters using various IoMT (Internet of Medical Things) devices. Founded in April 2022 by Rahul Kishore Singh, Manjari Chandra, Ramanpreet Singh, and Amit Acharya, Bonatra integrates clinical acumen with technology to achieve holistic health. Its solutions include personalized, targeted lifestyle, nutritional, and fitness interventions to balance hormones, correct gut dysbiosis, and harness natural detox procedures to reduce heavy metal toxicity in the body.
At StartupGlue, we’re here to help you navigate this overwhelming world of stuff. All of our market picks are independently selected and curated by the editorial team. All product details reflect the price and availability at the time of publication. If you buy something we link to on our site, Truoosh may earn commission.